Yoshitsugu Shitaka, Ph.D., President, Astellas Institute for Regenerative Medicine
Tokyo, Japan
Astellas Pharma is an innovative pharmaceutical company with global headquarters in Tokyo, Japan, conducting business in more than 70 countries around the world. Astellas is promoting the focus area approach that is designed to identify opportunities for the continuous creation of new drugs to address diseases with high unmet medical needs by focusing on biology and modality. Furthermore, the company is also looking beyond its foundational Rx focus to create Rx+® healthcare solutions that combine the company’s expertise and knowledge with cutting-edge technology in different fields of external partners. Through these efforts, Astellas stands on the forefront of healthcare change to turn innovative science into value for patients.

By using this website you agree to accept our Privacy Policy and Terms & Conditions